Introducing the new Instinct sensor, made by Abbott

Introducing Instinct Blog cover

Life with diabetes just got easier

The highly anticipated Instinct sensor, made by Abbott is now available to order in the U.S. bringing more sensor options for pump users.

This launch marks an exciting moment for the diabetes community, bringing together our top-performing insulin delivery system with a compact, longer-wear sensor. 

 

What is the Instinct sensor?

The Instinct sensor was created exclusively for the MiniMedTM 780G system. The integrated system provides real-time glucose readings, automated insulin delivery adjustments, and proactive alerts to help our customers spend less time worrying about their diabetes† and more time enjoying life’s moments. 

Instinct sensor highlights:

  • Easy one-handed insertion
  • Small and discreet1 wear — the size of two stacked pennies
  • 15-day wear time
  • One hour warm-up
  • No fingersticks required with SmartGuardTM technology‡  
  • No overtape
  • Labeled for people with type 1 diabetes


Sensor choice is here

Our expanded sensor selection allows our customers to choose the option that best fits their needs and lifestyle. In addition to the Instinct sensor, we also offer the:

  • Simplera SyncTM sensor: Designed for simplicity, this all-in-one disposable sensor can be applied with a one-handed insertion that takes less than 10 seconds! The Simplera SyncTM sensor is about the size of a quarter and does not require overtape. This option is available for people living with type 1 or type 2 diabetes.

  • GuardianTM 4 sensor: The GuardianTM 4 sensor delivers advanced accuracy and provides real-time glucose data with customizable alerts. This option is available for people with living type 1or type 2 diabetes. 


Check out our side-by-side CGM comparison to see the differences between sensor options for diabetes management.

Footnotes

† Refers to SmartGuard™ technology. Individual results may vary.
‡ Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.

References

1.    Data on file, Abbott Diabetes Care, Inc.

 

Important Safety Information: MiniMedTM 780G system with SmartGuardTM technology with Instinct sensor, Simplera SyncTM sensor, and GuardianTM 4 sensor

The MiniMedTM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMedTM 780G System includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM and GuardianTM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.

WARNING: Do not use MiniMedTM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMedTM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.

©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.

DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMedTM 780G system algorithm includes technology developed by DreaMed Diabetes.